MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Neuroectodermal Tumors

(UMLS:C0206093)

Definition:: Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.
UMLS ID:: C0206093
MeSH ID:: D017599

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625|C04.557.580.625

Synonym(s)

Neuroectodermal Tumors

Neuroectodermal neoplasm

Neuroectodermal tumor

Neuroectodermal tumor, NOS

Neuroectodermal tumour

Neuroectodermal tumour, NOS

neuroectodermal tumor

neuroectodermal tumors

neuroectodermal; tumor

10.

tumor; neuroectodermal

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Carboplatin	12837982	CTD
2	Cyclophosphamide	8761367 12837982	CTD
3	Irinotecan	8761367	CTD
4	Methotrexate	2854471	CTD
5	Methylprednisolone	8217541	CTD
6	Ondansetron	8217541	CTD
7	Thiotepa	8761367 12837982	CTD
8	Vincristine	12837982	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Chordoma	44.4%
2	Teratoma	44.4%
3	Germinoma	44.4%
4	Teratocarcinoma	44.4%
5	leukemia	40.9%
6	Neoplasms, Glandular and Epithelial	40.9%
7	Meningioma	37.8%
8	Dermoid Cyst	35.3%
9	Trophoblastic Neoplasms	35.1%
10	Carcinosarcoma	34.7%
11	Hemangiosarcoma	34.7%
12	lymphangiosarcoma	34.7%
13	Dysgerminoma	33%
14	Neuroma	33%
15	Seminoma	33%
16	Histiocytic Disorders, Malignant	30.5%
17	Carcinoma 256, Walker	29.9%
18	Basal cell carcinoma	29.5%
19	Carcinoma, Papillary	29.5%
20	Squamous cell carcinoma	29.5%
21	Chondrosarcoma	29.5%
22	Cystadenoma	29.5%
23	leiomyosarcoma	29.5%
24	liposarcoma	29.5%
25	Mesothelioma	29.5%
26	synovial sarcoma	29.5%
27	Angiomyolipoma	29.5%
28	Clear Cell Sarcoma of Soft Tissue	29.5%
29	Alveolar Soft Part Sarcoma	29.5%
30	Sarcoma, Myeloid	29.5%
31	Carcinoma, Basal Cell	29.5%
32	Choriocarcinoma	28.9%
33	Leukemia, Plasma Cell	27.6%
34	Neoplasms, Neuroepithelial	27.6%
35	Gliomatosis cerebri	27.6%
36	Cystadenocarcinoma	26.9%
37	Fibrosarcoma	26.9%
38	Osteosarcoma	26.9%
39	Mucoepidermoid Carcinoma	26.9%
40	Adenoma	26.7%
41	Ameloblastoma	26.7%
42	Angiokeratoma	26.7%
43	Carcinoma	26.7%
44	Hemangioma	26.7%
45	hemangiopericytoma	26.7%
46	Lymphangioma	26.7%
47	Mesenchymoma	26.7%
48	Nevus	26.7%
49	Hepatoblastoma	26.7%
50	Mixed Tumor, Mullerian	26.7%
51	Angiofibroma	26.7%
52	Sarcoma	26.7%
53	Epithelioma	26.7%
54	Composite Lymphoma	26.4%
55	Neurilemmoma	25.9%
56	Adenofibroma	25.7%
57	Fibroadenoma	25.7%
58	Malignant Fibrous Histiocytoma	25.7%
59	melanoma	25.5%
60	Carcinoma, Ehrlich Tumor	25.2%
61	Carcinoma, Lewis Lung	25.2%
62	Neurofibrosarcoma	24.5%
63	Bowen's Disease	24.4%
64	Rhabdomyosarcoma	24.4%
65	Giant Cell Tumor of Bone	24.4%
66	Lymphoma	24.3%
67	Leukemia, Experimental	24.2%
68	Hamartoma	23.8%
69	Neoplasms, Hormone-Dependent	23.8%
70	Neoplasms, Multiple Primary	23.8%
71	Paraneoplastic Syndromes	23.8%
72	Precancerous Conditions	23.8%
73	Neoplasms, Second Primary	23.8%
74	Dermatofibrosarcoma	23.1%
75	Dermatofibrosarcoma Protuberans	23.1%
76	Medulloblastoma	22.8%
77	Carcinoma, Lobular	22.3%
78	Alveolar rhabdomyosarcoma	21.9%
79	Leukemia L1210	21.5%
80	Leukemia P388	21.5%
81	Acanthoma	21.5%
82	Adenoma, Acidophil	21.4%
83	Ganglioneuroma	21.4%
84	Glioma	21.4%
85	Malignant Glioma	21.4%
86	Endometrial Stromal Sarcoma	21.1%
87	Neoplasms, Germ Cell and Embryonal	20.5%
88	Germ Cell Cancer	20.5%
89	Hutchinson's Melanotic Freckle	20.4%
90	Melanoma, Amelanotic	20.4%
91	Melanoma, Experimental	20.4%
92	Leukemia, Radiation-Induced	20.3%
93	Hydatidiform Mole	20.1%
94	Plasmacytoma	20%
95	Sarcoma, Experimental	20%
96	Neuroectodermal Tumors	20%
97	Thymoma	19.9%
98	Malignant histiocytosis	19.8%
99	Histiocytic sarcoma	19.8%
100	Adenocarcinoma	19.8%
101	Carcinoma in Situ	19.8%
102	Carcinoma, Transitional Cell	19.8%
103	Phyllodes Tumor	19.8%
104	Hemangioendothelioma	19.8%
105	Lipoma	19.8%
106	Myoma	19.8%
107	Myxoma	19.8%
108	Papilloma	19.8%
109	Pseudomyxoma Peritonei	19.8%
110	Papillomatosis	19.8%
111	Angiolipoma	19.8%
112	Myelolipoma	19.8%
113	Neoplasms, Bone Tissue	19.8%
114	Neoplasms, Fibrous Tissue	19.8%
115	Smooth Muscle Tumor	19.8%
116	Adenomatosis, Pulmonary	19.8%
117	Adenomatous Polyps	19.8%
118	Carcinoma, Large Cell	19.8%
119	Carcinoma, Small Cell	19.8%
120	Desmoplastic Small Round Cell Tumor	19.8%
121	Chondroma	19.8%
122	Enchondroma	19.8%
123	Lymphangioleiomyomatosis	19.6%
124	neurofibroma	19.5%
125	Carcinoid Tumor	19.4%
126	Sarcoma 180	18.9%
127	Astrocytoma	18.4%
128	Ependymoma	18.4%
129	oligodendroglioma	18.4%
130	Ganglioglioma	18.4%
131	gliosarcoma	18.4%
132	Anaplastic astrocytoma	18.4%
133	Anaplastic Oligodendroglioma	18.4%
134	Cyst	17.9%
135	Neoplastic Processes	17.9%
136	Neoplastic Syndromes, Hereditary	17.9%
137	Pregnancy Complications, Neoplastic	17.9%
138	Neoplasms, Experimental	17.5%
139	Malignant Carcinoid Syndrome	17.4%
140	Glioblastoma	16.9%
141	Neuroblastoma	16.9%
142	Glioblastoma Multiforme	16.9%
143	Adenoid Cystic Carcinoma	16.4%
144	fibroma	16.4%
145	Fibromatosis	16.4%
146	Osteoblastoma	16.4%
147	Osteoma	16.4%
148	Rhabdomyoma	16.4%
149	Chondromatosis	16.4%
150	Adenocarcinoma, Clear Cell	16.4%
151	Cholangiocarcinoma	16.4%
152	Cervical Intraepithelial Neoplasia	16.4%
153	Hemangioblastoma	16.4%
154	Lymphoma, Extranodal NK-T-Cell	16.4%
155	Ganglioneuroblastoma	16.1%
156	Hodgkin Disease	15.8%
157	Lymphoma, Non-Hodgkin	15.8%
158	Multiple Endocrine Neoplasia	15.7%
159	Craniopharyngioma	14.8%
160	Leukemia, Myelomonocytic, Chronic	14.8%
161	Lymphomatoid Granulomatosis	14.8%
162	Neuroectodermal Tumor, Melanotic	14.8%
163	Neuroendocrine Tumors	14.8%
164	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	14.8%
165	Fibromatosis, Aggressive	14.7%
166	Fibromatosis, Abdominal	14.7%
167	Klatskin Tumor	14.7%
168	Carcinoma, Pancreatic Ductal	14.7%
169	Retinoblastoma	14.3%
170	Basal Cell Nevus Syndrome	14.1%
171	Neoplasms, Radiation-Induced	14%
172	Acoustic Neuroma	14%
173	Carcinoid Heart Disease	13.9%
174	Paraneoplastic Encephalomyelitis	13.7%
175	Abdominal Neoplasms	13.6%
176	Erythroplasia	13.6%
177	Follicular cyst	13.6%
178	Head and Neck Neoplasms	13.6%
179	Mucocele	13.6%
180	Pilonidal Cyst	13.6%
181	Soft Tissue Neoplasms	13.6%
182	Thoracic Neoplasms	13.6%
183	Thyroglossal Cyst	13.6%
184	Synovial Cyst	13.6%
185	Aberrant Crypt Foci	13.6%
186	Nephroblastoma	13.5%
187	Mammary Neoplasms, Experimental	13.4%
188	Primary amyloidosis	13.3%
189	Hepatocellular Adenoma	13.2%
190	Mastocytoma	12.3%
191	Mastocytosis, Systemic	12.2%
192	Leukemia, Myeloid, Chronic-Phase	12.2%
193	Paraganglioma	12.2%
194	Mastocytosis	12.1%
195	Sturge-Weber Syndrome	12.1%
196	Gastrointestinal Stromal Tumors	11.9%
197	Hemangioma, Cavernous	11.8%
198	Leukemia, T-Cell	11.8%
199	Mesoblastic Nephroma	11.8%
200	Leukemia, B-Cell	11.8%
201	Lymphoma, Follicular	11.7%
202	T-Cell Lymphoma	11.7%
203	Mantle cell lymphoma	11.7%
204	Prolactinoma	11.2%
205	Growth Hormone-Secreting Pituitary Adenoma	11.2%
206	Tuberous Sclerosis	11.1%
207	Pheochromocytoma	10.9%
208	Vipoma	10.8%
209	Digestive System Neoplasms	10.7%
210	Endocrine Gland Neoplasms	10.7%
211	Eye Neoplasms	10.7%
212	Nervous System Neoplasms	10.7%
213	Multiple Endocrine Neoplasia Type 1	10.4%
214	Bone neoplasms	10.3%
215	Leukoplakia	10.3%
216	Lymphocele	10.3%
217	Pancreatic Cyst	10.3%
218	Skin Neoplasms	10.3%
219	Hematologic Neoplasms	10.3%
220	Optic Nerve Glioma	10.2%
221	Barrett Esophagus	10.2%
222	Breast Cyst	10.2%
223	Actinic keratosis	10.2%
224	Mediastinal Cyst	10.2%
225	Neoplasm Invasiveness	10.2%
226	Neoplasm Metastasis	10.2%
227	Neoplasm Recurrence, Local	10.2%
228	Parovarian Cyst	10.2%
229	Pericardial Cyst	10.2%
230	Splenic Neoplasms	10.2%
231	Thymic Cyst	10.2%
232	Carcinogenesis	10.2%
233	Myxoid cyst	10.2%
234	Metastasis	10.2%
235	insulinoma	10.1%
236	Waldenstrom Macroglobulinemia	9.9%
237	Multiple Myeloma	9.9%
238	granulosa cell tumor	9.7%
239	Carcinoma, Ovarian Epithelial	9.7%
240	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	9.7%
241	Leukemia, Large Granular Lymphocytic	9.7%
242	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	9.7%
243	Lymphoma, T-Cell, Cutaneous	9.7%
244	Lymphoma, AIDS-Related	9.7%
245	Enteropathy-Associated T-Cell Lymphoma	9.7%
246	Primary Effusion Lymphoma	9.7%
247	Gastrinoma	9.5%
248	Glucagonoma	9.5%
249	Adenomatous Polyposis Coli	9.3%
250	Adrenocortical carcinoma	9.3%
251	Parathyroid Neoplasms	9.1%
252	Peritoneal Neoplasms	9.1%
253	Thyroid Neoplasm	9.1%
254	Thyroid carcinoma	9.1%
255	Dupuytren Contracture	9%
256	Retroperitoneal Neoplasms	8.9%
257	Urticaria Pigmentosa	8.8%
258	Leydig Cell Tumor	8.7%
259	Mycosis Fungoides	8.7%
260	Lymphomatoid Papulosis	8.7%
261	Plasmablastic lymphoma	8.7%
262	Liver Neoplasms, Experimental	8.6%
263	Nasopharyngeal carcinoma	8.1%
264	Renal Cell Carcinoma	8.1%
265	Papillary Renal Cell Carcinoma	8.1%
266	Corpus Luteum Cyst	8%
267	Ovarian Cysts	8%
268	Tracheal Neoplasms	7.9%
269	Pancreatic Neoplasm	7.8%
270	Carcinoma, Endometrioid	7.8%
271	Leukoplakia, Oral	7.7%
272	Paraneoplastic Cerebellar Degeneration	7.7%
273	Denys-Drash Syndrome	7%
274	Burkitt Lymphoma	6.9%
275	Choledochal Cyst	6.8%
276	Mouth Neoplasms	6.8%
277	Central Nervous System Neoplasms	6.8%
278	Vascular Neoplasms	6.8%
279	Thymus Neoplasms	6.8%
280	Genital Neoplasms, Female	6.7%
281	Pancreatic Pseudocyst	6.7%
282	Peutz-Jeghers Syndrome	6.6%
283	Esophageal Neoplasms	6.6%
284	Lymphatic Metastasis	6.6%
285	Neoplasms, Unknown Primary	6.6%
286	Leukemic Infiltration	6.6%
287	Breast Neoplasms, Male	6.6%
288	Neoplasm Micrometastasis	6.6%
289	Triple Negative Breast Neoplasms	6.6%
290	Thyroid Nodule	6.6%
291	Limbic Encephalitis	6.6%
292	Sezary Syndrome	6.3%
293	Lambert-Eaton Myasthenic Syndrome	5.9%
294	Testicular Neoplasms	5.9%
295	Adrenal Gland Neoplasms	5.5%
296	Gastrointestinal Neoplasms	5.5%
297	Genital Neoplasms, Male	5.5%
298	Liver neoplasms	5.5%
299	Uveal Neoplasms	5.5%
300	Urologic Neoplasms	5.4%
301	Sebaceous Gland Neoplasms	5.3%
302	Spinal Neoplasms	5.3%
303	Bone Marrow Neoplasms	5.3%
304	Polycystic Ovary Syndrome	5.2%
305	Opsoclonus-Myoclonus Syndrome	5.2%
306	Meningeal Neoplasms	5%
307	Myelitis, Transverse	4.6%
308	Nose Neoplasms	4.5%
309	Palatal Neoplasms	4.5%
310	Ear Neoplasms	4.1%
311	Eyelid Neoplasms	4.1%
312	Lung Neoplasms	4.1%
313	Pleural Neoplasms	4.1%
314	Meningeal Carcinomatosis	4.1%
315	Xeroderma Pigmentosum	4%
316	Pituitary Adenoma	4%
317	Pituitary Neoplasms	4%
318	Cell Transformation, Viral	4%
319	Brain Neoplasms	4%
320	Salivary Gland Neoplasms	4%
321	Spinal Cord Neoplasms	4%
322	Tongue Neoplasms	4%
323	Uterine Neoplasms	3.9%
324	Vaginal Neoplasms	3.9%
325	Vulvar Neoplasms	3.9%
326	Uterine Cancer	3.9%
327	Fallopian Tube Neoplasms	3.9%
328	ovarian neoplasm	3.8%
329	Pharyngeal Neoplasms	3.4%
330	Central Nervous System Cysts	3.4%
331	Bronchial Neoplasms	3.3%
332	Bile Duct Neoplasms	3.3%
333	gallbladder neoplasm	3.3%
334	Intestinal Neoplasms	3.3%
335	Penile Neoplasms	3.3%
336	Prostatic Neoplasms	3.3%
337	Stomach Neoplasms	3.3%
338	Multiple Pulmonary Nodules	3.3%
339	Polycythemia Vera	3.3%
340	Supratentorial Neoplasms	3.3%
341	Endometrial Neoplasms	3.2%
342	Laryngeal neoplasm	3%
343	Zollinger-Ellison syndrome	2.9%
344	Brain Stem Neoplasms	2.9%
345	Bladder Neoplasm	2.8%
346	Kidney Neoplasm	2.8%
347	Ureteral Neoplasms	2.8%
348	Urethral Neoplasms	2.8%
349	Hypopharyngeal Neoplasms	2.8%
350	Pleural Effusion, Malignant	2.8%
351	Hypopharyngeal Cancer	2.8%
352	Choroid Plexus Papilloma	2.7%
353	Parotid Neoplasms	2.7%
354	Prostatic Neoplasms, Castration-Resistant	2.7%
355	Nelson Syndrome	2.7%
356	Tonsillar Neoplasms	2.4%
357	Cerebellar Neoplasms	2.4%
358	Cecal Neoplasms	2.3%
359	Duodenal Neoplasms	2.3%
360	Radicular Cyst	2.1%
361	Nasopharyngeal Neoplasms	2.1%
362	Appendiceal Neoplasms	2.1%
363	Colonic Neoplasms	2.1%
364	Rectal Neoplasms	2.1%
365	Colorectal Neoplasms	2%
366	Paranasal Sinus Neoplasms	1.8%
367	Anus Neoplasms	1.7%
368	Sigmoid Neoplasms	1.7%
369	Maxillary Sinus Neoplasms	1.6%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262